These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6927374)

  • 1. [Transrecters. A new group of inducers of reverse transformation with possible use in the treatment of human cancer].
    Gosálvez M; Blanco MF; de Paz E
    Rev Esp Oncol; 1982; 29(4):821-6. PubMed ID: 6927374
    [No Abstract]   [Full Text] [Related]  

  • 2. On the irreproducibility of thioproline.
    Gosalvez M
    Biomed Pharmacother; 1982; 36(8-9):387-8. PubMed ID: 7182022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioproline: an inhibitor of chemical carcinogenesis.
    Parks RC; Jones T; Banks AR; Hessek E
    Neoplasma; 1982; 29(5):535-7. PubMed ID: 7177244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytostatic and reverse-transforming therapies of cancer - a brief review and future prospects.
    McCarty MF
    Med Hypotheses; 1982 Jun; 8(6):589-612. PubMed ID: 6180286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic and toxicologic evaluation of thioproline: a proposed nontoxic inducer of reverse transformation.
    Newman RA; Hacker MP; McCormack JJ; Krakoff IH
    Cancer Treat Rep; 1980; 64(8-9):837-44. PubMed ID: 7448821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current aspects of drug therapy of cancer].
    Vicente J
    Rev Clin Esp; 1970 Dec; 119(6):501-16. PubMed ID: 4928318
    [No Abstract]   [Full Text] [Related]  

  • 7. [New approach to the treatment of malignant diseases using cytostatic drugs. (Comprehensive review)].
    Klener P
    Vnitr Lek; 1974 May; 20(5):476-84. PubMed ID: 4602412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Optimally spaced after-treatment with multiplicative effect. A cancer therapy principle of universal character].
    von Ardenne M
    Arch Geschwulstforsch; 1973; 42(4):324-44. PubMed ID: 4371114
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary clinical results with norgamem (thioproline) and revercan (2-amino-2-thiazoline): the first inducers of reverse transformation.
    Brugarolas A; Gosálvez M
    Recent Results Cancer Res; 1982; 80():346-50. PubMed ID: 7036296
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRC as a target for anti-cancer drugs.
    Levitzki A
    Anticancer Drug Des; 1996 Apr; 11(3):175-82. PubMed ID: 8663905
    [No Abstract]   [Full Text] [Related]  

  • 12. Some considerations on the role of chemotherapy in individualization of cancer therapy.
    Tagnon HJ
    Strahlentherapie; 1984 Nov; 160(11):681-3. PubMed ID: 6506107
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of cis-dichlorodiammineplatinum (II) and Acronycin on the proliferation and respiration of HeLa cells in vitro.
    Kovarík J; Svec F; Thurzo V
    Neoplasma; 1972; 19(6):569-77. PubMed ID: 4670379
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of cancer.
    Lancet; 1983 Apr; 1(8328):799-800. PubMed ID: 6132134
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cellular kinetics and cytostatics].
    Brincker H
    Ugeskr Laeger; 1971 May; 133(19):923-5. PubMed ID: 4934537
    [No Abstract]   [Full Text] [Related]  

  • 16. [The individualized therapy of tumors].
    Mattern J; Volm M
    Dtsch Med Wochenschr; 1992 Oct; 117(44):1685-9. PubMed ID: 1425274
    [No Abstract]   [Full Text] [Related]  

  • 17. [Individual chemotherapy of solid tumors].
    Volm M; Mattern J
    Med Welt; 1976 Jun; 27(24):1171-6. PubMed ID: 781458
    [No Abstract]   [Full Text] [Related]  

  • 18. Tailoring Ras-pathway--inhibitor combinations for cancer therapy.
    Blum R; Kloog Y
    Drug Resist Updat; 2005 Dec; 8(6):369-80. PubMed ID: 16356760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies: aiming for the bull's-eye.
    Gaguski ME
    ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.